Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Päätekijä: | Khandker, Tahia Anjum |
---|---|
Muut tekijät: | Kabir, Eva Rahman |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2024
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/22046 |
Samankaltaisia teoksia
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Tekijä: Islam, Nahidul
Julkaistu: (2023) -
Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
Tekijä: Mahin, Md. Tamjidur Rahman
Julkaistu: (2024) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Tekijä: Afroza, Halima
Julkaistu: (2024) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
Tekijä: Bishakha, Adwiza Chakraborty
Julkaistu: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Tekijä: Meem, Manila
Julkaistu: (2023)